Global Digital Store – Ebooks and Softwares

Tag: Proven

  • WHO and UNICEF to partner on pandemic response through COVID-19 Solidarity Response Fund

    WHO and UNICEF as we speak introduced an settlement to work collectively on COVID-19 response, through the historic COVID-19 Solidarity Response Fund powered by the United Nations Foundation and Swiss Philanthropy Foundation.  

    The COVID-19 Solidarity Response Fund has been arrange to facilitate an unprecedented world response by supporting the WHO Strategic Preparedness and Response Plan. As a part of the settlement, an preliminary portion of the cash from
    the Fund – which presently stands at greater than $127 million – will circulate to UNICEF for its work with susceptible kids and communities everywhere in the world.

    “COVID-19 is an unprecedented pandemic requiring extraordinary global solidarity to urgently respond,” stated Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “I’m happy that UNICEF joined the Solidarity
    Response Fund. With their in depth expertise each in fundraising and in implementing programmes, this partnership will assist us to work collectively carefully to save lives.”

    The cash collected through the fund can be used, amongst others, to practice and equip communities and health-care staff to forestall, detect and deal with COVID-19. It will assist international locations broaden their health-care capability and mitigate its social impression, particularly
    on girls, kids and susceptible social teams. And it should speed up analysis and improvement of therapies and preventive vaccines.

    As a key partner on this joined-up effort, UNICEF will lead emergency efforts to guarantee households and communities in probably the most susceptible international locations are totally engaged within the response and have entry to water, sanitation and hygiene and different an infection prevention
    and management measures. UNICEF may even guarantee kids, caretakers, and frontline responders corresponding to social staff, academics and healthcare staff are supported through evidence-based steering through its huge group outreach and nation
    packages.

    “This is an extraordinary emergency that demands an extraordinary response, and we need all-hands on deck—individuals, corporations, foundations, governments and other organizations around the world,” stated UNICEF Executive Director Henrietta
    Fore. “UNICEF is happy to be a part of the Solidarity Response Fund. It will bolster our efforts to strengthen well being and sanitation techniques and assist shield probably the most susceptible households from knock-on impacts of COVID-19 on already overstretched well being
    techniques.”

    Funds raised can be spent in alignment with the worldwide response plan, and the place wants are biggest. At the path of WHO management, it’s anticipated that sources will go immediately towards:

    • WHO, for its work to monitor the unfold of the virus, assess gaps and wants, equip frontline well being staff with private protecting gear, guarantee lab and testing instruments can be found in international locations around the globe, and maintain communities
      and frontline responders knowledgeable with the most recent technical steering.
    • UNICEF, to guarantee kids and households around the globe are outfitted with all of the evidence-based data and newest WHO steering in addition to domestically related data to shield themselves from the unfold of COVID-19; to assist
      susceptible international locations by offering entry to water, sanitation and hygiene, and primary an infection prevention and management measures; and to present entry to look after susceptible households and kids.
    • CEPI, the Coalition for Epidemic Preparedness Innovations, a key partner main the financing for analysis and improvement for novel vaccines to fight COVID-19, working carefully with WHO.

    The COVID-19 Solidarity Response Fund was arrange at WHO’s request by the UN Foundation and Swiss Philanthropy Foundation and launched three weeks in the past. It is the one manner for people and organizations to contribute immediately to WHO’s
    world efforts to deal with the pandemic. To date the fund has $127 million raised or dedicated from greater than 219,000 people from everywhere in the world plus greater than 90 world corporations and organizations. The partnership can be an amazing
    demonstration of solidarity throughout UN organizations in coordinating, partnering and supporting one another in coping with the instant and longer-term impression of the pandemic. 

    “There has never been a more urgent need for global cooperation,” stated Elizabeth Cousens, President & CEO of the UN Foundation. “The COVID-19 pandemic reveals us that all of us can play a component to cease the unfold. The unimaginable
    generosity proven to the COVID-19 Solidarity Response Fund from around the globe will assist WHO, UNICEF, CEPI and companions speed up their lifesaving work, particularly to assist probably the most susceptible communities and velocity the event of a
    vaccine.”

    ###

    Notes to editors

    About UNICEF

    UNICEF works in a few of the world’s hardest locations, to attain the world’s most deprived kids. Across greater than 190 international locations and territories, we work for each little one, in every single place, to construct a greater world for everybody.

    About WHO

    WHO is the United Nations’ specialised company for well being. It is an inter-governmental group and works in collaboration with its Member States often through the Ministries of Health. The World Health
    Organization is accountable for offering management on world well being issues, shaping the well being analysis agenda, setting norms and requirements, articulating evidence-based coverage choices, offering technical assist to international locations and monitoring
    and assessing well being tendencies. Learn extra at www.who.int.

    About the United Nations Foundation

    The UN Foundation brings collectively concepts, folks, and sources to assist the United Nations drive world progress and deal with pressing issues. Our hallmark is to collaborate for lasting change and innovate to handle humanity’s biggest challenges.
    Learn extra at www.unfoundation.org.

    Read More
    https://www.who.int/news-room/detail/03-04-2020-who-and-unicef-to-partner-on-pandemic-response-through-covid-19-solidarity-response-fund

    Views: 0

  • 7 Proven Strategies For Going Viral

    I stunned myself final month when my new free reward went viral. Since I?m stuffed with curiosity, I wished to know why? so I deconstructed the expertise, on the lookout for the teachings. I requested a few of the individuals who helped me go viral what was so engaging to them? and got here up with this mix of the 7 methods I used.

    Read More
    http://www.associationofmarketing.org/articles/view.php?article_id=6093

    Views: 0

  • New WHO Guide to help countries expand access to essential medicines

    New WHO Guide to help countries expand access to essential medicines

    WHO’s   new user guide for countries, ‘Selection of medicines at country level’, is based on the WHO Model List of Essential Medicines. It sets out the key actions countries should undertake to develop and update their own
    national essential medicines lists based on the treatment needs of their populations and their capacity to reimburse payments for medicines.

    The document also aims to support countries in progressing towards universal health coverage. Today, approximately half of the world’s population is unable to  access essential medicines. The large majority of these people live in poorer countries,
    but rising prices of new medicines are also becoming a challenge for health systems in wealthy countries.

    A careful selection of essential medicines is the first step in ensuring a population can obtain the quality-assured medicines it needs at an affordable price.  Countries need to do more to ensure that all people and communities can access highly
    effective medicines. WHO’s new manual is a resource to do just that. 

    The document, intended for policy makers in charge of national medicines and reimbursement lists, aims to increase transparency on how essential medicines are selected. Most national lists of essential medicines have several differences when compared
    with WHO’s model list, which lists only medicines of proven safety and efficacy. Some national lists include medicines that bring little extra benefit to patients. Decision-makers should refer to the WHO global list to gauge the public health
    value of listing certain medicines for their populations.

    The essential medicines concept 

    Essential medicines are: 

    • those that satisfy the priority health care needs of the population
    • selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety, and comparative cost-effectiveness
    • intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and community can afford.  

    The essential medicines concept is global and forward-looking. It incorporates the need to regularly update medicines selections to reflect new therapeutic options and changing therapeutic needs; the need to ensure drug quality; and the need for continued
    development of better medicines, medicines for emerging diseases and medicines to meet changing resistance patterns.

    Achieving universal health coverage and equity in public health depends on access to essential, high-quality and affordable health related technologies for all. To achieve access for all by 2030, at least two billion more people will need to have access
    to essential health services by 2030.

    In an effort to make the Model List of Essential Medicines more readily accessible, WHO recently developed an electronic version of the list, bringing the traditional EML to computer screens, tablets and smartphones in a freely accessible, downloadable,
    online database.

    Link to manual: Selection of essential medicines at country level

    Link to e-EML: Model List of Essential Medicines

    New WHO Guide to help countries expand access to essential medicines
    Read More
    https://www.who.int/news-room/detail/30-03-2020-new-who-guide-to-help-countries-expand-access-to-essential-medicines

    Views: 0

  • World TB Day 2020: It’s Time for solidarity

    World TB Day 2020: It’s Time for solidarity

    At this unique time in history when the world is grappling with the COVID-19 pandemic, the WHO Department of Global HIV, Hepatitis and STI Programmes stands in solidarity with governments and communities as they seek to maintain health services
    and continue to address the needs of patients suffering from HIV and tuberculosis (TB). 

    Despite being preventable and treatable, tuberculosis remains the world’s biggest infectious killer and the leading cause of death among people living with HIV (PLHIV), responsible for 32% of the 770 000 lives lost to HIV in 2018. People
    living with HIV are far more vulnerable (nearly 20 times more) to TB infection than people without HIV and are three times more likely to die during TB treatment.  

    While there are proven interventions that reduce TB deaths – such as provision of TB preventive treatment, adoption of novel diagnostics for earlier TB diagnosis and linkage to treatment, and antiretroviral therapy (ART) – we are far behind
    in scaling these up, and diagnostic and treatment gaps remain, with only half of estimated TB cases among PLHIV reaching care in 2018, only half of estimated PLHIV with TB receiving ART, and less than half of PLHIV new on ART initiating TB preventive
    treatment in a subset of countries which reported globally.

    On this World TB Day, WHO highlights two key interventions to reduce unnecessary TB deaths among PLHIV: 

    • (1) provision of TB preventive treatment for all eligible PLHIV; and 
    • (2) increased uptake of newer diagnostic tests such as the lateral flow urine lipoarabinomannan assay (TB-LAM.) 

    As the new Director for the Department of Global HIV, Hepatitis and STI Programmes, I support current efforts to continue and to take to scale TB activities. It’s Time for solidarity!

    -Meg Doherty, Director Global HIV, hepatitis and STI Programmes, WHO

    HIV programmes are encouraged to ensure that TB preventive treatment, including shorter WHO-recommended regimens, with updated guidance launched today, are provided to all eligible PLHIV as part of a routine package of care, including provision of ART, and that treatment completion is ensured.   

    In recent months, WHO has also released guidelines for use of a bedside urine TB-LAM test to accelerate earlier TB diagnosis, with significantly expanded eligibility criteria. As this test is “point of care” with the potential for earlier
    TB diagnosis and treatment initiation, HIV programmes should consider these recommendations as they enhance strategies for TB diagnosis among PLHIV, including as part of a routine package of advanced HIV care. 

    It’s Time to urgently scale up TB preventive treatment and TB diagnosis and strengthen referral and linkages to TB treatment at HIV service delivery points in all countries and continue to scale-up ART among PLHIV with TB. This applies to all populations
    at risk, including children, pregnant women and marginalized groups, to ensure no one is left behind.

    WHO calls for continued collaboration in countries across health programmes for harmonized and integrated policies and service delivery, and engagement with communities and other sectors. Unless HIV programmes scale up interventions to close these
    gaps in prevention, diagnosis and treatment both for TB and HIV, countries and their development partners will not meet our common target: a 75% reduction in TB deaths among PLHIV between 2010 and 2020. HIV mortality cannot be reduced without addressing
    the leading cause: tuberculosis.

     

    World TB Day 2020: It’s Time for solidarity
    Read More
    https://www.who.int/news-room/detail/24-03-2020-world-tb-day-2020-it-s-time-for-solidarity

    Views: 0

  • Global gathering of ministers determines road safety agenda to 2030

    The 3rd Global Ministerial Conference on Road Safety convened 1700 delegates from around 140 countries, including more than 70 ministers and vice-ministers and heads of international agencies, civil society organizations, foundations and private companies. Hosted at the request of the UN General Assembly by the Government of Sweden in collaboration with WHO, the theme was “Achieving Global Goals 2030”, highlighting the connections between road safety and achievement of other Sustainable Development Goal targets.

    Through its 6 high-level panels and 18 parallel sessions, the Ministerial Conference addressed a range of topics, from building effective leadership for road safety to promoting sustainable cities and communities, mitigating climate change through road safety, and ensuring the safety of pedestrians and cyclists. The gathering was instrumental in reviewing progress in the Decade of Action for Road Safety 2011-2020 and defining ways to accelerate action on proven strategies to save lives. Among many pre-events, the 2nd World Youth Assembly for Road Safety hosted by YOURS: Youth for Road Safety and co-hosted by WHO, brought 200 young leaders together proclaiming “Enough is enough!” and claiming their space at the decision-making table for sustainable mobility.

    The Ministerial Conference culminated in the forward-looking “Stockholm Declaration”, which calls for a new global target to reduce road traffic deaths and injuries by 50% by 2030. In addition, it invites strengthened efforts on activities in all five pillars of the Global Plan for the Decade of Action: better road safety management; safer roads, vehicles and people; and enhanced post-crash care. It also calls for speeding up the shift to safe, affordable, accessible and sustainable modes of transport like walking, cycling and public transport. WHO is asked to continue to produce the series of global status reports, as a means of monitoring progress towards achievement of the 12 Global Road Safety Performance Targets.

    Today, around 1.35 million people lose their lives on the world’s roads every year, and as many as 50 million are injured. More than one quarter of those killed and injured are pedestrians and cyclists. Road traffic injuries are now the leading cause of death for children and young adults aged 5-29 years. Given the enormous human suffering and major economic losses for families and societies, road traffic deaths remain an unacceptable price to pay for mobility.

    Read More
    https://www.who.int/news-room/detail/20-02-2020-global-gathering-of-ministers-determines-road-safety-agenda-to-2030

    Views: 0

  • WHO outlines steps to save 7 million lives from cancer

    WHO outlines steps to save 7 million lives from cancer

    The World Health Organization (WHO) today spells out the need to step up cancer services in low and middle-income countries. WHO warns that, if current trends continue, the world will see a 60% increase in cancer cases over the next two decades. The greatest increase (an estimated 81%) in new cases will occur in low- and middle-income countries, where survival rates are currently lowest.

    This is largely because these countries have had to focus limited health resources on combating infectious diseases and improving maternal and child health, while health services are not equipped to prevent, diagnose and treat cancers. In 2019, more than 90% of high-income countries reported that comprehensive treatment services for cancer were available in the public health system compared to less than 15% of low-income countries.

    “This is a wake-up call to all of us to tackle the unacceptable inequalities between cancer services in rich and poor countries,” says Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/ Communicable and Noncommunicable Diseases, World Health Organization. “If people have access to primary care and referral systems then cancer can be detected early, treated effectively and cured. Cancer should not be a death sentence for anyone, anywhere.”

    Yet, progress in poorer countries is achievable. WHO and the International Agency for Research on Cancer (IARC) are releasing two coordinated reports on World Cancer Day (4 February), in response to government calls for more research into the scope and potential policies and programmes to improve cancer control.

    “At least 7 million lives could be saved over the next decade, by identifying the most appropriate science for each country situation, by basing strong cancer responses on universal health coverage, and by mobilizing different stakeholders to work together”, said Dr Tedros Adhanom Ghebreyesus, Director-General, WHO.

    WHO highlights a wide range of proven interventions to prevent new cancer cases. These include controlling tobacco use (responsible for 25% of cancer deaths), vaccinating against hepatitis B to prevent liver cancer, eliminating cervical cancer by vaccinating against HPV, screening and treatment, implementing high-impact cancer management interventions that bring value for money and ensuring access to palliative care including pain relief.

    “The past 50 years have seen tremendous advances in research on cancer prevention and treatment,” says Dr Elisabete Weiderpass, Director of IARC. “Deaths from cancer have been reduced. High-income countries have adopted prevention, early diagnosis and screening programmes, which together with better treatment, have contributed to an estimated 20% reduction in the probability of premature mortality between 2000 and 2015, but low-income countries only saw a reduction of 5%. We need to see everyone benefitting equally.” The challenge will be for countries to select treatments balancing considerations including cost, feasibility and effectiveness. Each government is tasked with choosing the appropriate innovative cancer therapies, while recognizing that established treatments, many of which are very effective and affordable, can provide benefits for cancer without causing financial hardship.

    Note to editors

    World Health Organization

    Report on Cancer: Setting priorities, investing wisely and providing care for all

    The report aims to set the global agenda on cancer, mobilize stakeholders and help countries set priorities for investing in cancer control and universal health coverage. It introduces the principles, tools and current priority cancer control interventions in the context of the current and future cancer burden and opportunities.

    International Agency for Research on Cancer

    World Cancer Report “Cancer research for cancer prevention”

    The report focuses on prevention and offers the most comprehensive overview of relevant research available to date, ranging from descriptive etiology, cellular and molecular biology, toxicology and pathology through to behavioural and social science. Key chapters include discussions on the impact of inequalities in cancer, vaccination and screening, genomic individual susceptibility to cancer and the finer identification of those at risk, which may allow ‘precision cancer prevention’.

    WHO outlines steps to save 7 million lives from cancer
    Read More
    https://www.who.int/news-room/detail/04-02-2020-who-outlines-steps-to-save-7-million-lives-from-cancer

    Views: 0

  • Statement on the meeting of the International Health Regulations (2005) Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo on 12 February 2020

    Statement on the meeting of the International Health Regulations (2005) Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo on 12 February 2020

    The meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) to review the current Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) took place on Wednesday, 12 February 2020, from 14:00 to 16:45 Geneva time (CEST).

    Proceedings of the meeting

    Members and advisors of the Emergency Committee were convened by teleconference.

    The Secretariat welcomed the Committee and thanked them for their support. The meeting was turned over to the Chair, Dr Robert Steffen.

    Dr Steffen also welcomed the Committee and gave the floor back to the Secretariat.

    Representatives of WHO’s legal department and the department of compliance, risk management, and ethics briefed the Committee members on their roles and responsibilities.

    Committee members were reminded of their duty of confidentiality and their responsibility to disclose personal, financial, or professional connections that might be seen to constitute a conflict of interest. Each member who was present was surveyed and no conflicts of interest were judged to be relevant to the meeting.

    The Chair then reviewed the agenda for the meeting and introduced the presenters.

    Presentations were made by representatives of the Ministry of Health of the Democratic Republic of the Congo (DRC), the WHO Secretariat, and the UN Ebola Emergency Response Coordinator.

    The current situation in the DRC was reviewed. As of 10 February 2020, there were a total of 3431 cases, of which 3308 were confirmed and 123 were probable. 2253 persons have died (66%). Between 3 and 9 February 2020, three new confirmed cases were reported in Beni Health Zone, North Kivu. These three cases were already registered as contacts and two were under surveillance at the time of detection. More than 2000 contacts are being followed. There has been an increase in the number of security incidents in recent months.

    Challenges that remain include: strengthening of community acceptance for full commitment to response measures; protection of personnel at strategic health checkpoints; improvement of infection prevention and control practices in health facilities; strengthening of the local health system; and comprehensive treatment and support for patients in recovery.

    The WHO Secretariat gave an overview of the epidemiological situation, which shows an overall encouraging trend in case incidence and geographic spread. It was noted that sustaining this progress depends on the security situation and control of the well-known drivers of transmission, particularly in traditional health facilities, and on continued trust and communication with the community.

    A risk communication and community engagement programme has been developed, as has an EVD survivors programme. It is critical to ensure the long-term sustainability of these two initiatives.   

    The situation in countries neighbouring DRC was reviewed, as was preparedness in nonaffected areas of DRC. An EVD operational readiness standardized approach has been implemented in 9 priority countries. More than 2400 alerts have been investigated, and more than 14,600 health workers have been vaccinated.

    The UN Ebola Emergency Response Coordinator gave a brief report on operational support, focused on security challenges and preparations for any resurgence of disease.

    Context and Discussion

    The Committee noted a great deal of progress in the situation since its last meeting and commended the response, under the leadership of the DRC Ministry of Health and the multisectoral coordination commission established in July 2019. Support provided by WHO, UN agencies, nongovernmental organizations and other partners has also contributed to limiting the spread and impact of this virus in a difficult context. An increase in the number of alerts was attributed to strong and proactive community surveillance.

    Conclusions and Advice

    It was the unanimous view of the Committee that this event still constitutes a public health emergency of international concern (PHEIC) under the IHR (2005).

    The Committee acknowledged the revised risk assessment, which puts the risk now as high at national and regional levels, and low at the global level.

    The Committee was concerned that withdrawing the PHEIC now might have adverse consequences for the response efforts through diminishing focus. Additionally, although the primary concern of the Committee is EVD, there are serious ongoing outbreaks of other diseases, including measles and cholera, in DRC. The country continues to need support to combat infectious diseases as well as to strengthen its health system. Further, there remains an urgent need to maintain international solidarity for the response.

    The Committee noted the ongoing discussions about the interpretation in the text of the IHR (2005) of the terms international and regional spread, and about creating an intermediate level of response between the binary possibilities of PHEIC or no PHEIC, in a way that does not require reopening negotiations on the Regulations. The Committee supports these discussions, as an intermediate level would be as useful for gradually ending a PHEIC and for signaling the potential for one to be declared.

    The Committee provided the following advice to the Director-General for his issuance as revised Temporary Recommendations under the IHR (2005).

    For DRC:

    • Sustain the political commitment and multisectoral coordination approach to the response.
    • Continue to engage and build trust with associations of survivors to facilitate rapid detection of any cases arising from exposure to infected bodily fluids of survivors.
    • Continue to strengthen capacity, implementation, and coordination for community awareness and engagement, including a focus on hotspots, preventing resurgence where cases have declined, and to support survivors in their communities.
    • Further enhance the acceptance of response measures and address access and security issues by engaging influencers and decision makers for all interventions.
    • Strengthen measures to prevent and manage nosocomial infections, including systematic mapping of health facilities, targeting of IPC interventions and sustain support to those facilities through monitoring and supervision, including in private-sector and traditional health facilities.
    • Continue cross-border screening and step up monitoring at checkpoints around hotspots and at main roads.
    • Continue to implement and share real-time full-genome genetic sequencing of all new confirmed cases.
    • Strengthen measures to prevent and manage nosocomial infections, including systematic mapping of health facilities, targeting of IPC interventions and sustain support to those facilities through monitoring and supervision.
    • Strengthen preparedness in non-affected provinces of DRC, and more generally strengthen the health system across the country to respond to concurrent health emergencies.
    • Continue to implement optimal vaccine strategies that have proven maximum impact on curtailing the outbreak, as recommended by WHO’s Strategic Advisory Group of Experts (SAGE).

    For countries at risk:

    • At-risk countries should maintain their work with partners to improve their preparedness for detecting and managing imported or locally acquired cases, including the transparent sharing of detailed information on suspect cases, as required by the International Health Regulations (2005), and sharing laboratory samples of suspect cases for confirmatory testing in accordance with WHO norms and guidance.
    • Countries should continue to map population movements and sociological patterns that can predict risk of disease spread.
    • Risk communications and community engagement, especially at points of entry, should be maintained.

    For all countries:

    • As recommended previously, no country should close its borders or place any restrictions on travel and trade.
    • The Committee does not consider entry screening at airports or other ports of entry outside the region to be necessary.

    The Committee emphasized the importance of continued support by WHO and other national and international partners towards the effective implementation and monitoring of these recommendations.

    Based on this advice, the reports made by the affected State Party, and the currently available information, the Director-General accepted the Committee’s assessment and on 12 February 2020 maintained the Ebola outbreak in the Democratic Republic of the Congo as a Public Health Emergency of International Concern (PHEIC).

    The Director-General endorsed the Committee’s advice and issued them as Temporary Recommendations under IHR (2005) to reduce the international spread of Ebola, effective 12 February 2020. The Director-General thanked the Committee Members and Advisors for their advice and requested their reassessment of this situation within two months or earlier if the situation requires.

    Statement on the meeting of the International Health Regulations (2005) Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo on 12 February 2020
    Read More
    https://www.who.int/news-room/detail/12-02-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-for-ebola-virus-disease-in-the-democratic-republic-of-the-congo-on-12-february-2020

    Views: 0

  • Ministers to agree new global road safety agenda to 2030

    Ministers to agree new global road safety agenda to 2030

    Government ministers and senior officials from over 100 countries will meet in Stockholm, Sweden from 19-20 February to discuss new steps to halve road traffic deaths and injuries by 2030, in line with global targets agreed in the United Nations Sustainable Development Goals (SDGs).

    “The fact that an estimated 1.35 million lives are lost every year due to road traffic collisions is an outrage. It is an unacceptable price to pay for mobility,” said Dr Tedros Adhanom Ghebreyesus, Director-General at the World Health Organization (WHO).

    Road traffic injuries are now the leading cause of death for children and young adults aged 5 to 29 years, according to WHO’s most recent Global status report on road safety.

    More than half of all road traffic deaths occur among pedestrians, cyclists and motorcyclists. The risk of a road traffic death remains three times higher in low-income countries than in high-income countries. Moreover, as many as 50 million people experience non-fatal road injuries, which impose human suffering and major economic losses.

    “Most road traffic deaths and injuries can be prevented, using tried and tested strategies,” added Dr Tedros. “This conference is an opportunity for the world to embrace a new agenda to radically reduce the number of lives lost on our roads and re-think how we can provide access to safe, affordable, accessible and sustainable transport systems for all.”

    Progress in road safety

    Many countries have already made progress through effective road safety management and focusing on better legislation and enforcement around key risks such as speeding; drinking and driving, and failing to use seatbelts. They have also improved infrastructure through measures such as safer sidewalks and dedicated lanes for cyclists; implemented vehicle standards such as those that mandate advanced braking and electronic stability control; and enhanced post-crash care.

    Improvements have occurred when a number of sectors have been involved – including transport, health, urban planning and law enforcement, among others. Success has also depended mainly on strong leadership and political will at the highest level of government and in close collaboration with civil society and the private sector.

    The Stockholm Declaration

    Hosted by the Government of Sweden in collaboration with WHO, the 3rd Global Ministerial Conference on Road Safety offers delegates an opportunity to share successes and lessons learned, chart future strategic directions for global road safety, and define ways to fast-track progress around proven strategies to save lives.

    The Stockholm Declaration will be presented as the final outcome document of the Ministerial Conference calling for strong political will and international cooperation as well as partnerships across many sectors of society. The Declaration will lay out key recommendations for accelerated action to drive progress towards halving global road traffic deaths and injuries by 2030.

    Beyond preventing human suffering and major economic losses, addressing road traffic deaths and injuries has positive impact across all aspects of society and development ─ including those linked to environment, climate change, education, employment, energy, poverty, human rights and equality ─ as outlined in the SDG targets.

    Note to editors:

    Road safety is reflected in the SDGs agreed in 2015, with two dedicated targets: (a) 3.6 aimed at preventing road traffic deaths and injuries and (b) 11.2 providing access to safe, affordable, accessible and sustainable transport systems for all.

    Achieving these targets would lead to increases in walking, cycling and using public transport, in other words, those modes of transport which impact most favorably on noncommunicable diseases like heart and lung diseases, cancer and diabetes. It would also contribute to reducing environmental risks, such as air and noise pollution, and steering sustainable urbanization, with less congestion and universal access to safe, inclusive and green public spaces. 

    Ministers to agree new global road safety agenda to 2030
    Read More
    https://www.who.int/news-room/detail/07-02-2020-ministers-to-agree-new-global-road-safety-agenda-to-2030

    Views: 0

  • Herpes Genitalis Cure

    [ad_1]

    You’ll be glad to hear that, despite the so-called medical ‘facts’ you’ve probably heard or read, which say there is no cure for Herpes Genitalis, there is another more positive view.

    There is evidence that it is possible not just to find effective natural treatment for viral infections such as Herpes & even AIDS, but even to experience a complete cure.

    So far medical research has found no way to eradicate Herpes.

    So if you’ve tested positive for the virus you’ve probably been told there are now drugs to treat the symptoms and shorten the length of the acute attack – but that you can never get rid of the Herpes virus altogether.

    That would mean that even when you are over the first attack and you are no longer showing any symptoms the virus is still in your system and later you will probably have a flare up intermittently and need another course of treatment.

    However – it seems there are other much better possibilities than those offered medically.

    I certainly believe there are more effective ways to deal with the virus than you will be offered medically.

    The first time I saw someone successfully use a natural health method to prevent any recurrence of Herpes Genitalis was in someone who took large amounts of Tahitian Noni Juice for natural healing and then continued to take it on a regular basis over many years – and never had a recurrence of the virus after the first proven infection.

    Though she was convinced the Noni juice had saved her from further problems it is of course impossible to say whether the result was due to the Noni juice or to some other factor – such as her absolute belief in this natural treatment, for example, or perhaps some other factor in her diet or in her life – including perhaps her own healing powers that she was not at that time aware of.

    In fact it is always impossible to be certain in human beings what is the cause of a cure when it does occur – whether the person used medical or natural treatment – because there are always so many other factors that could have been involved. Even when someone takes a drug and gets better for example we cannot be certain it was the drug that produced the healing – for the same reasons.

    However – the point is – this girl was cured – by something – which shows that healing is possible.

    Over the years I have studied and used various forms of natural healing – from diets and supplements – to energy healing, laughter therapy and mind training – in an attempt to help patients who were not getting results with medical treatment or who wanted to avoid the side-effects of various medications. And although not everyone was cured there have been many cases where the healing results have been far beyond medical possibility and medical explanation.

    While still running my own medical practice for example I saw some amazing results with natural treatments. One lady was cured completely of pancreatic cancer. Another – who had been suffering severe infected psoriasis all over her body for many years – despite all medical treatments – was completely clear within a month of starting a natural treatment.

    And early in 2011 I modified my own already successful natural healing techniques after learning about university laboratory studies in which a 100% cancer cure was produced in mice – using only natural healing.

    You can learn about home remedies, experience free natural healing for Herpes Genitalis or learn how to do natural healing for yourself at Jersey Natural Health.com.

    [ad_2]

    Source by Dr Anne Curtis

    Views: 0